[Federal Register Volume 87, Number 79 (Monday, April 25, 2022)]
[Notices]
[Pages 24305-24306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-08704]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-22-0978]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Emerging Infections Program (EIP)'' to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on January 31, 2022, to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Emerging Infections Program (OMB Control No. 0920-0978, Exp. 4/30/
2022)--Revision--National Center for Emerging and Zoonotic Infectious 
Diseases (NCEZID), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The Emerging Infections Programs (EIPs) are population-based 
centers of excellence established through a network of state health 
departments collaborating with academic institutions; local health 
departments; public health and clinical laboratories; infection control 
professionals; and healthcare providers. EIPs assist in local, state, 
and national efforts to prevent, control, and monitor the public health 
impact of infectious diseases.
    Activities of the EIPs fall into the following general categories: 
(1) Active surveillance; (2) applied public health epidemiologic and 
laboratory activities; (3) implementation and evaluation of pilot 
prevention/intervention projects; and (4) flexible response to public 
health emergencies. These activities are designed to: (1) Address 
issues that the EIP network is particularly suited to investigate; (2) 
maintain sufficient flexibility for emergency response and new problems 
as they arise; (3) develop and evaluate public health interventions to 
inform public health policy and treatment guidelines; (4) incorporate 
training as a key function; and (5) prioritize projects that lead 
directly to the prevention of disease.
    A Revision is being submitted to make existing collection 
instruments clearer and to add several new forms specifically surveying 
laboratory practices. These forms will allow the EIP to better detect, 
identify, track changes in laboratory testing methodology, gather 
information about laboratory utilization in the EIP catchment area to 
ensure that all cases are being captured, and survey EIP staff to 
evaluate program quality.
    Total estimated burden is 61,956 hours. There is no cost to 
respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of       Number of      burden per
          Type of respondent                    Form name           respondents    responses per   response  (in
                                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
State Health Department...............  ABCs Case Report Form...              10             809           20/60
                                        ABCs Invasive                         10             127           10/60
                                         Pneumococcal Disease in
                                         Children and Adults
                                         Case Report Form.
                                        ABCs H.influenzae                     10               6           10/60
                                         Neonatal Sepsis
                                         Expanded Surveillance
                                         Form.
                                        ABCs Severe GAS                       10             136           20/60
                                         Infection Supplemental
                                         Form.
                                        ABCs Neonatal Infection               10              37           20/60
                                         Expanded Tracking Form.
                                        FoodNet Campylobacter...              10             970           21/60
                                        FoodNet Cyclospora......              10              42           10/60
                                        FoodNet Listeria                      10              16           20/60
                                         monocytogenes.
                                        FoodNet Salmonella......              10             855           21/60
                                        FoodNet Shiga toxin                   10             290           20/60
                                         producing E. coli.
                                        FoodNet Shigella........              10             234           10/60
                                        FoodNet Vibrio..........              10              46           10/60
                                        FoodNet Yersinia........              10              55           10/60

[[Page 24306]]

 
                                        FoodNet Hemolytic Uremic              10              10               1
                                         Syndrome Case Report
                                         Form.
                                        FoodNet Clinical                      10              70           20/60
                                         Laboratory Practices
                                         and Testing Volume.
                                        FluSurv-NET Influenza                 10             764           25/60
                                         Hospitalization
                                         Surveillance Network
                                         Case Report Form.
                                        FluSurv-NET Influenza                 10             333            5/60
                                         Hospitalization
                                         Surveillance Project
                                         Vaccination Phone
                                         Script Consent Form
                                         (English).
                                        FluSurv-NET Influenza                 10             333            5/60
                                         Hospitalization
                                         Surveillance Project
                                         Vaccination Phone
                                         Script (Spanish).
                                        Influenza                             10             333            5/60
                                         Hospitalization
                                         Surveillance Project
                                         Provider Vaccination
                                         History Fax Form
                                         (Children/Adults).
                                        FluSurv-NET Laboratory                10              16           10/60
                                         Survey.
                                        HAIC--MuGSI Case Report               10             500           28/60
                                         Form for Carbapenem-
                                         resistant
                                         Enterobacteriaceae
                                         (CRE) and Acinetobacter
                                         baumannii (CRAB).
                                        HAIC--MuGSI Extended-                 10            4200           25/60
                                         Spectrum Beta-Lactamase-
                                         Producing
                                         Enterobacteriaceae
                                         (ESBL/iEC).
                                        HAIC--Invasive                        10             340           28/60
                                         Methicillin-resistant
                                         Staphylococcus aureus
                                         (MRSA) Infection Case
                                         Report Form.
                                        HAIC--Invasive                        10             584           28/60
                                         Methicillin-sensitive
                                         Staphylococcus aureus
                                         (MSSA) Infection Case
                                         Report Form.
                                        HAIC--CDI Case Report                 10            1650           38/60
                                         and Treatment Form.
                                        HAIC Candidemia Case                  10             200           30/60
                                         Report.
                                        HAIC--Annual Survey of                10              16           19/60
                                         Laboratory Testing
                                         Practices for C.
                                         difficile Infections.
                                        HAIC--CDI Annual                      10               1           15/60
                                         Surveillance Officers
                                         Survey.
                                        HAIC--Emerging                        10              45            5/60
                                         Infections Program C.
                                         difficile Surveillance
                                         Nursing Home Telephone
                                         Survey (LTCF).
                                        HAIC--Invasive                        10              11           20/60
                                         Staphylococcus aureus
                                         Laboratory Survey.
                                        HAIC--Invasive                        10               1           10/60
                                         Staphylococcus aureus
                                         Supplemental
                                         Surveillance Officers
                                         Survey.
                                        HAIC--Laboratory Testing              10              20           12/60
                                         Practices for
                                         Candidemia
                                         Questionnaire.
                                        HAIC MuGSI CA CP-CRE                 100              10           30/60
                                         Health interview (new).
                                        HAIC MuGSI Supplemental               10               1           15/60
                                         Surveillance Officer
                                         Survey (new).
                                        HAIC Death Ascertainment              10               8         1440/60
                                         Variables.
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-08704 Filed 4-22-22; 8:45 am]
BILLING CODE 4163-18-P